The peroxisome-cholesterol-Yap network was not found in another inflammatory disease of the gastrointestinal tract in our study, suggesting that this network could be specific for IBD-type intestinal inflammation, and it could be targeted in novel therapies. Here, YAP1 is linked to inflammatory bowel disease.